The board of directors of CANbridge Pharmaceuticals Inc. announced that the principal place of business of the Company in Hong Kong will be changed to Room B01, 20/F, CITIC Tower, 1 Tim Mei Avenue, Admiralty, Hong Kong with effect from April 15, 2024. The website of the Company remain unchanged.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 HKD | -4.23% | -25.27% | -65.66% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-65.66% | 19.3M | |
+8.12% | 72.94B | |
-10.56% | 5.07B | |
+51.87% | 4.78B | |
+4.07% | 3.9B | |
-14.26% | 2.56B | |
+21.27% | 2.42B | |
-26.13% | 2.39B | |
+19.31% | 2.18B | |
+3.66% | 1.65B |
- Stock Market
- Equities
- 1228 Stock
- News CANbridge Pharmaceuticals Inc.
- CANbridge Pharmaceuticals Inc. Announces Change of Principal Place of Business in Hong Kong, Effect from April 15, 2024